Lifecore Biomedical, Inc. \de\ (LFCR) · Oct 20, 2026 · Acquisition

Lifecore merger advances as November 4 record date is set

Special meeting process — November 4, 2026 record date

Lifecore’s merger process moves toward a shareholder vote, but this 8-K adds timing mechanics—not new deal economics or approval.

Lifecore is a sterile-injectables contract development and manufacturing organization that is being taken private by Webster Equity Partners under the merger announced September 27, 2026. This filing advances the deal administratively, not economically. The board set November 4, 2026 as the stockholder record date for the special meeting. 〔0〕 That determines which holders can vote; it does not itself approve the transaction, set a meeting date, change the merger consideration, or confirm closing.

The next meaningful step is proxy disclosure. Lifecore says it will file a preliminary proxy statement and intends to file a definitive proxy statement, which will provide the detailed information stockholders need before voting. 〔1〕 Because the merger itself was already publicly announced, this notice is confirmation of an expected process milestone rather than a fresh deal surprise.

Bottom line: The merger is moving through the expected shareholder-approval process, but this 8-K does not materially change the deal or Lifecore’s underlying business story. It matters as a procedural step, not as new transaction information.

What to watch next

Preliminary proxy statement filing

Original filing on SEC EDGAR

More Lifecore Biomedical, Inc. \de\ news

Lifecore merger advances as November 4 record date is set | LFCR Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.